Table 3.
Group A (≥3 Treatment Cycles), n = 10 | Group B (≤2 Treatment Cycles), n = 14 | P | ||
Post-ligation invasive MV duration (day), median (min–max) | 18 (8-43) | 15.5 (7-22) | .196 | U |
Post-ligation non-invasive MV duration (day), median (min–max) | 14.5 (5-28) * | 15.5 (3-44) | .494 | U |
Post-ligation oxygen therapy duration (day), median (min–max) | 19.5 (6-22) * | 20 ( 9-36) | .607 | U |
Total (pre + post) invasive MV duration (day), median (min–max) | 46 (28-79) | 32 ( 24- 44) | .004 | U |
Hospitalization time day, median (min–max) | 100 (83-120)* | 79 (56-129) | .101 | U |
Postconceptional week at discharge, (mean ± SD) | 40 ± 2* | 38.9 ± 2.2 | .248 | t |
Discharge weight, grams, (mean ± SD) | 2563 ± 493* | 2543 ± 594 | .937 | t |
BPD | χ2 | |||
Mild | 0 (0) | 1 (7.1) | .019 | |
Moderate | 3 (30) | 11 (78.6) | ||
Severe | 7 (70) | 2 (14.3) | ||
ROP | χ2 | |||
no | 1 (10) | 1 (7.1) | ||
Stage 1 | 1 (10) | 7 (50) | .216 | |
Stage 2 | 5 (50) | 3 (21.4) | ||
≥Stage 3 | 3 (30) | 3 (21.4) | ||
PVL, n (%) | 1 (10) | 1 (7.1) | .803 | χ2 |
Mortality, n (%) | 2 (20) | 0 (0) | .081 | χ2 |
*Group A was evaluated by excluding patients with mortality results (n = 8).
MV, mechanical ventilation; BPD, bronchopulmonary dysplasia; ROP, retinopathy of prematurity; PVL, periventricular leucomalasia; χ 2 , chi-square test; t, independent samples t-test.